Literature DB >> 25128446

Pediatric cochlear implant revision surgery and reimplantation: an analysis of 957 cases.

Yüksel Olgun1, Asuman Feda Bayrak2, Tolgahan Catli2, Mehmet Emrah Ceylan2, Ruhi Aydin2, Ufuk Duzenli2, Levent Olgun2.   

Abstract

OBJECTIVE: In this study causes, risk factors, prevention strategies, diffuculties encountered during revision cochlear implant surgery, reimplantation in pediatric age group were evaluated.
METHODS: Charts of 957 CI patients younger than 18 years of age implanted at Izmir Bozyaka Teaching and Research Hospital between 1998 and July 2012 and 18 referred CI complications at same age group were retrospectively evaluated. Revision and reimplantation surgeries were systematically reviewed.
RESULTS: We encountered 26 surgical complications in 24 patients and 36 device related problems in 36 patients. Eighteen referred cases including 7 surgical complications and 11 device related problems were also evaluated. A total number of 80 complications were evaluated. In 11 cases conservative management was successful, 19 revision surgery was performed but we failed in 4 cases. We reimplanted 48 cases and 4 additional cases were implanted after failed revision surgery. Implant was extracted in one case. In one case we could implant the other side. Forty-six of reimplantations were done in one stage surgery, 5 cases required second stage surgery.
CONCLUSIONS: Surgical complications and device related problems of cochlear implantation may be different in children and majority of them require revision surgery or reimplantation. Although surgical problems leading to revision surgery and reimplantation are expected to diminish by experience every center has to deal with device failures. Both revision surgery and reimplantation require extra care and it should be better carried out by experienced surgeons. Implant performances are expected to be comparable with primary implantations.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cochlear implantation; Reimplantation; Revision surgery

Mesh:

Year:  2014        PMID: 25128446     DOI: 10.1016/j.ijporl.2014.07.013

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  7 in total

1.  Evaluating Reasons for Revision Surgery and Device Failure Rates in Patients Who Underwent Cochlear Implantation Surgery.

Authors:  So Yeon Kim; Min Bum Kim; Won-Ho Chung; Yang-Sun Cho; Sung Hwa Hong; Il Joon Moon
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

2.  [Hearing restoration with cochlear implants after translabyrinthine vestibular schwannoma resection].

Authors:  C Bohr; S Müller; J Hornung; U Hoppe; H Iro
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

3.  Management of Complications in 1452 Pediatric and Adult Cochlear Implantations.

Authors:  Muhammed Dağkıran; Özgür Tarkan; Özgür Sürmelioğlu; Süleyman Özdemir; Elvan Onan; Ülkü Tuncer; Sümbül Bayraktar; Mete Kıroğlu
Journal:  Turk Arch Otorhinolaryngol       Date:  2019-12-19

4.  Analysis and Management of Complications in a Cohort of 1,065 Minimally Invasive Cochlear Implantations.

Authors:  Yi Jiang; Ping Gu; Beicheng Li; Xue Gao; Baochun Sun; Yueshuai Song; Guojian Wang; Yongyi Yuan; Cuicui Wang; Miao Liu; Dongyi Han; Pu Dai
Journal:  Otol Neurotol       Date:  2017-03       Impact factor: 2.311

5.  Endoscope-Assisted Cochlear Implantation.

Authors:  Enis Alpin Güneri; Yüksel Olgun
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-12-01       Impact factor: 3.372

6.  Feasibility of Revision Cochlear Implant Surgery for Better Speech Comprehension.

Authors:  Kyurin Hwang; Jae Yong Lee; Hyeon Seok Oh; Byung Don Lee; Jinsei Jung; Jae Young Choi
Journal:  J Audiol Otol       Date:  2019-03-13

7.  Cochlear implant failure: diagnosis and treatment of soft failures.

Authors:  Eyal Yosefof; Ohad Hilly; David Ulanovski; Eyal Raveh; Joseph Attias; Meirav Sokolov
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-12       Impact factor: 2.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.